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environment

BANGLADESH
Recommendations
• Communicate national
PE/E policy and guidelines to all stakeholders,
program managers, and
service providers.

POLICIES FOR PRE-ECLAMPSIA AND ECLAMPSIA
PREVENTION AND MANAGEMENT
Each day, more than 830 women and 7,200 babies die from pregnancy- or childbirth-related causes. These complications also lead to 7,000 stillbirths daily.
Ninety nine percent of these deaths occur in developing countries. Despite global efforts to reduce preventable maternal and newborn mortality, Bangladesh
still experiences between 5,000 and 6,000 maternal deaths each year. Of those
deaths, 20 percent are from pre-eclampsia and eclampsia (PE/E), the second
most common direct cause of maternal mortality in the country. These deaths are
preventable.
In Bangladesh, best practices to prevent PE/E using aspirin and calcium and
manage through task sharing and using magnesium sulphate (MgSO4) and antihypertensive drugs have not been optimally examined.

RESEARCH

AUGUST 2017

To appreciate the enormity of the problem, the Population Council conducted a
landscape analysis in 12 upazilas in four districts. The study was cross sectional,
and data collection activities included in-depth interviews (IDIs) with policy makers, development partners, program managers, and Ob/Gyn professionals and
primary facility providers. The study’s objective was to identify existing national
policies and guidelines for PE/E management and prevention, as well as to document gaps in antenatal care (ANC) specifically related to PE/E.

Made possible by the generous support of the
American people through the United States
Agency for International Development (USAID).

• Distribute national policies throughout the health
system, including primary
facilities.
• National policies include
prevention and management of PE/E protocols
at secondary and tertiary
facilities.
• Train providers at primary
and secondary facilities
on prevention and management of PE/E.
• Collaborate with pharmaceutical companies to
manufacture and package
single IM loading dose of
MgSO4.
• Introduce task sharing
policy for the administration of aspirin and antihypertensive drugs by primary facility providers.
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FINDINGS
Government policies
National policies for maternal health and standard operating procedures encompass prevention and management of complications like PE/E, but there is no specific
policy that outlines detection, prevention, and treatment.
A developed, tested, and approved protocol for primary
health care (PHC) providers, ready for implementation in
the field, has not yet been circulated, and program managers and service providers are unaware it exists.

“I don’t know about the government policy. There
might be one, but I cannot tell you about it, as I
didn’t get the policy in my hand. I don’t know about
where the policy is being implemented. There is no
implementation policy in my district or upazilas.”
Policy Maker and Program Manager, MoHFW
Task sharing

Central Medical Store of Drugs (CMSD) to District Reservation Stores (DRS). If these medicines are supplied to
DRS, they are either stored there or sent to the district
hospitals (DH) or upazila health complexes (UHC), depending upon the need.
The DGHS allocates 20 percent of its budget to the CMSD
to locally procure medicines, including antihypertensive
drugs, usually purchased quarterly through CMSD or by
local purchase through a competitive bidding process. In
exploring the reasons for irregular supply of these drugs,
where the incidence of PE/E is lower, facilities appear to
not use the drugs frequently and many drugs in expire on
the shelves.
Prevention measures
Aspirin is not seen as a preventive drug for PE/E and
there is no policy. Calicum is regularly supplied to pregnant women during ANC, although many providers are
unaware of its use in preventing pre-eclampsia.
Improving the referral system

Interviewees were aware of evidence about task sharing
for detecting and managing PE/E using the loading dose
of MgSO4 and referring women to secondary and tertiary
facilities. Almost all policy level respondents believe that
task sharing to lower cadre providers can have a positive
impact on maternal health outcomes. They stressed the
need for proper training and mentoring of lower level providers, however.

“We say that we made progress toward the MDG
goals, but still most of the deliveries are taking
place at home. If there is any problem, they first
come to the grass roots health workers. If we can
make the service providers more aware and train
them at the community level, then they can identify
PE/E, administer the loading dose of MgSO4, and
refer. Then it will definitely have a good effect and
will reduce maternal mortality.”
UNFPA Participant
Essential drugs for PE/E
Magnesium sulphate, calcium gluconate and antihypertensive drugs are essential for providing comprehensive
treatment of PE/E. The Directorate General of Family
Planning (DGFP) does not suppy these drugs to its facilities, rather, they expect pregnant women presenting with
PE/E to be referred to a higher level facility with the appropriate medicines. In the Directorate General of Health
Services (DGHS), MgSO4 and calcium gluconate (the antidote to MgSO4 toxicity) are supplied irregularly by the

Interviewees were evenly divided about functionality of
the current referral system. Half of the respondents believe it functions well, while others disagree. All belive it
needs to be strengthened, however.

“In the health system, the entry and exit points for
a patient are not fixed. For the common cold, patients are going to Dhaka Medical College Hospital,
as well as to Community Clinics. Then how does the
referral system work? Sending the patient with only
a referral slip is not a true referral. It is not followed
appropriately. We need to discuss the issue of the
referral system at national level.”
		

Deputy Director, DGFP

Reducing deaths from PE/E in Bangladesh is possible.
Essential drugs and equipment must be available in facilities, and providers at all tiers of the health system must
know detection, prevention, and treatment measures
and be able to refer women for management.
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